Board Appointments

RNS Number : 0474N
Plant Health Care PLC
18 January 2023
 

18 January 2023

 

PLANT HEALTH CARE plc 

("Plant Health Care" or the "Company")

 

Board Appointments

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel peptides for plant protection to global agriculture markets, is pleased to announce the appointments of Kate Coppinger and James Ede-Golightly as Non-Executive Directors.

Kate Coppinger is an experienced Non-Executive Director with an extensive background in investment banking and transaction execution. Having started her career as a research analyst at CIBC World Markets, she joined Harrison Lovegrove in 2000 and continued in her role, which focused on M&A transactions, within Standard Chartered Bank until 2020 following its acquisition of Harrison Lovegrove in 2007.

James Ede-Golightly has over twenty years of experience as a professional investor and director of growth companies. His current roles include Executive Chairman of Oxehealth and Non-Executive Director of Silence Therapeutics Plc. He co-founded Ora Capital Partners in 2006 having been an analyst at Commerzbank AG and Merrill Lynch Investment Managers. James previously served as a Non-Executive Director of Plant Health Care, between June 2013 and November 2016.

 

Chris Richards, Non-Executive Chairman of Plant Health Care, commented :

"We are delighted Kate has joined the Board. Her background in M&A and regulated industries will be an asset in terms of the Company's future product development and geographic expansion.

"In addition, it is great to welcome James back to the Company to help us capture the growth opportunities that we have identified.

"Maintaining the right balance of skills and experience on the Board is one of the keys to our continued progress. These appointments strengthen the Company and we look forward to working with Kate and James as we deliver our exciting growth proposition."

 

For further information, please contact:

 

Plant Health Care plc


Jeffrey Tweedy, Chief Executive Officer

Tel: +1 919 926 1600

Jeffrey Hovey, Chief Financial Officer

 

Cenkos Securities plc - Nomad & Broker 

Neil McDonald / Pete Lynch 

 

 

Tel: + (0) 131 220 9771

 



SEC Newgate (Financial Communications)

Tel:+44 (0)7540 10666

Robin Tozer / George Esmond

Email: phc@secnewgate.co.uk

 

 

The following information regarding the appointment of Kate Coppinger and James Ede-Golightly is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies:

Full Name:

Katherine Jane Coppinger

Age:

52

Shareholding in the Company:

-

 Current Directorship / Partnerships:

  iGas Energy plc

The Barnes Fund Trustee Limited

Serica Energy plc

Previous Directorship / Partnerships:

-

 

Full Name:

James Lawrence Ede-Golightly

Age:

43

Shareholding in the Company:

625,608 ordinary shares

Current Directorship / Partnerships:

Dunheved Limited

East Balkan Properties Plc

Guernsey Chamber of Commerce

Ora Global Ltd

Oxeco Limited

Oxehealth Limited

Sarossa Plc

Serendipity Capital Limited

Silent Therapeutics Plc

Previous Directorship / Partnerships:

DeepMatter Group Plc

Fermain Capital Limited

Gulfsands Petroleum Plc

Ora Limited

Oxford Advanced Surfaces Ltd

Quoram Limited (previously Quoram Plc)

 

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

About Plant Health Care plc

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at  www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBGDBDXBDGXR
UK 100

Latest directors dealings